Objective: To estimate the direct medical cost of glaucoma in Morocco and identify the factors associated with it. Methods: A cost-of-illness study was carried out to determine the direct medical cost of glaucoma in Morocco between November 2021 and February 2022. Patients with glaucoma who had received treatment for at least 12 months were recruited from Hassan II University Hospital, and were investigated from a societal perspective. The bottom-up costing method was used to estimate annual direct costs. Result: Overall, 151 patients were included while the mean age was 59.1 ± 8.9 years with a female predominant (57.6%). The direct medical cost of glaucoma was estimated to be 406.61 USD with 95% CI: 318.36 - 494.86 annually per patient, with medical treatment being the most expensive healthcare service. Advanced age, duration of illness, and severity of glaucoma were found to be associated with higher direct medical costs. Conclusion: The economic burden of managing glaucoma is expected to continue rising, which highlights the importance of early detection and effective policies based on cost-of-illness analyses to optimize spending and reduce the burden on the healthcare system.
Cite this paper
Maiouak, M. , Taybi, H. E. O. , Berraho, M. , Abdellaoui, M. , Fakir, S. E. , Andaloussi, I. B. and Tachfouti, N. (2023). Medical Direct Cost of Glaucoma in Morocco. Open Access Library Journal, 10, e001. doi: http://dx.doi.org/10.4236/oalib.1110001.
Cook, C. and Foster, P. (2012) Epidemiology of Glaucoma: What’s New? Canadian Journal of Ophthalmology, 47, 223-226. https://doi.org/10.1016/j.jcjo.2012.02.003
Chakib, A., Ouarrach, N., Haloui, M., Elbelhadji, M. and Amraoui, A. (2010) [Viscocanalostomy: Preliminary Clinical Results]. Journal Français d’Ophtalmologie, 33, 403-407. https://doi.org/10.1016/j.jfo.2010.03.009
Golics, C.J., Basra, M.K.A., Salek, M.S. and Finlay, A.Y. (2013) The Impact of Patients’ Chronic Disease on Family Quality of Life: An Experience from 26 Specialties. International Journal of General Medicine, 6, 787-798.
https://doi.org/10.2147/IJGM.S45156
Lee, P.P., Walt, J.G., Doyle, J.J., Kotak, S.V., Evans, S.J., Budenz, D.L., et al. (2006) A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma. Archives of Ophthalmology, 124, 12-19.
https://doi.org/10.1001/archopht.124.1.12
Fiscella, R.G., Lee, J., Davis, E.J.H. and Walt, J. (2009) Cost of Illness of Glaucoma. PharmacoEconomics, 27, 189-198.
https://link.springer.com/article/10.2165/00019053-200927030-00002
https://doi.org/10.2165/00019053-200927030-00002
Meier-Gibbons, F. and Töteberg-Harms, M. (2020) Influence of Cost of Care and Adherence in Glaucoma Management: An Update. Journal of Ophthalmology, 2020, Article ID: 5901537. https://www.hindawi.com/journals/joph/2020/5901537/
https://doi.org/10.1155/2020/5901537
Fukuda, Y., Kume, A. and Kashiwagi, K. (2021) Medical Costs of and Changes in Glaucoma Treatment among Patients Newly Starting Glaucoma Care. Current Eye Research, 46, 1695-1702.
https://www.tandfonline.com/doi/abs/10.1080/02713683.2021.1912780
https://doi.org/10.1080/02713683.2021.1912780
Traverso, C.E., Walt, J.G., Kelly, S.P., Hommer, A.H., Bron, A.M., Denis, P., et al. (2005) Direct Costs of Glaucoma and Severity of the Disease: A Multinational Long Term Study of Resource Utilisation in Europe. British Journal of Ophthalmology, 89, 1245-1249. https://doi.org/10.1136/bjo.2005.067355
Shiell, A., Gerard, K. and Donaldson, C. (1987) Cost of Illness Studies: An Aid to Decision-Making? Health Policy, 8, 317-323.
https://www.sciencedirect.com/science/article/abs/pii/0168851087900078
https://doi.org/10.1016/0168-8510(87)90007-8
Bloom, B.S., Bruno, D.J., Maman, D.Y. and Jayadevappa, R. (2001) Usefulness of US Cost-of-Illness Studies in Healthcare Decision Making. PharmacoEconomics, 19, 207-213. https://link.springer.com/article/10.2165/00019053-200119020-00007
https://doi.org/10.2165/00019053-200119020-00007
Cello, K.E., Nelson-Quigg, J.M. and Johnson, C.A. (2000) Frequency Doubling Technology Perimetry for Detection of Glaucomatous Visual Field Loss. American Journal of Ophthalmology, 129, 314-322.
https://doi.org/10.1016/S0002-9394(99)00414-6
Cours de référence. BANK AL-MAGHRIB.
https://www.bkam.ma/fr/Marches/Principaux-indicateurs/Marche-des-changes/Cours-de-change/Cours-de-reference?date=31%2F12%2F2020&block=cc51b5ce6878a3dc655dae26c47fddf8#address-5312b6def4ad0a94c5a992522868ac0a-cc51b5ce6878a3dc655dae26c47fddf8
Fu, D.J., Ademisoye, E., Shih, V., McNaught, A.I. and Khawaja, A.P. (2023) Burden of Glaucoma in the United Kingdom: A Multicenter Analysis of United Kingdom Glaucoma Services. Ophthalmology Glaucoma, 6, 106-115.
https://doi.org/10.1016/j.ogla.2022.08.007
Rahman, M.Q., Beard, S.M., Discombe, R., Sharma, R. and Montgomery, D.M.I. (2013) Direct Healthcare Costs of Glaucoma Treatment. British Journal of Ophthalmology, 97, 720-724. https://doi.org/10.1136/bjophthalmol-2012-302525
Real, J., Lafuente, M., Palma, S. and Tártara, L. (2020) Direct Costs of Glaucoma: Relationship between Cost and Severity of the Disease. Chronic Illness, 16, 266-274.
https://doi.org/10.1177/1742395318803660
Koleva, D., Motterlini, N., Schiavone, M. and Garattini, L. (2007) Medical Costs of Glaucoma and Ocular Hypertension in Italian Referral Centres: A Prospective Study. OPH, 221, 340-347. https://doi.org/10.1159/000104765
Wang, J.-C. and Chew, P.T.K. (2004) What Is the Direct Cost of Treatment of Acute Primary Angle Closure Glaucoma? The Singapore Model. Clinical & Experimental Ophthalmology, 32, 578-583. https://doi.org/10.1111/j.1442-9071.2004.00906.x
Ovreiu, S., Cristescu, I., Balta, F., Sultana, A. and Ovreiu, E. (2020) Early Detection of Glaucoma Using Residual Networks. 2020 13th International Conference on Communications (COMM), Bucharest, 18-20 June 2020, 161-164.
https://doi.org/10.1109/COMM48946.2020.9141990
